Skip to main content
. 2020 Oct 23;11:580250. doi: 10.3389/fimmu.2020.580250

Table 1.

Clinical characteristics, comorbidities, severity scores, nonspecific markers, metabolic parameters at the time of enrollment.

Variable Value Normal range
Number of patients 15
Patients’ characteristics
 Age (y.o.) 66 [60; 72]/(54|75)
 Gender (male) 12 (80)
 BMI (kg/m²) 29 [24.5; 32]/(22|43)
Comorbidities
 Diabetes 4 (26.7)
 Hypertension 7 (46.7)
 Obesity 6 (40)
 BMI 1 (6.7)
 COPD 2 (13.3)
 Asthma 1 (6.7)
 SAS 2 (13.3)
 Smoker 2 (13.3)
 Cancer 5 (33.3)
On admission
 Delay 1st Symptoms 9 [7; 14]/(1|18)
 SAPS2 49 [42; 65]/(22|80)
 SOFA 7 [4; 8]/(4|12)
 SOFA resp 3 [3; 4]/(0|4)
Corticosteroids 3 (20)
Nonspecific markers of inflammation
 PCT (miss=2) 0.9 [0.5; 3.1]/(0.1|37)
 CRP (miss=1) mg/ml 174.4 [134; 284]/(85|389.2) 0;0–10.0
 LDH 439.5 [397; 525]/(388|885) 120–246
 Ferritin (miss=3) (µg/l) 888.5 [451; 2385]/(348|7200) 22–322
 Ddimers (miss=1) (µg/l) 1742 [1599; 3220]/(804|10000) 45–500
 Fibrinogen (miss=2) (g/l) 7.8 [6.5; 8.2]/(4.3|9.9) 1.7–4
 C3 (miss=7) (g/l) 1.6 [1.4; 1.8]/(1.2|2.4) 0.9–1.7
 C4 (miss=7) (g/l) 0.4 [0.3; 0.4]/(0.3|0.5) 0.12–0.36
Metabolic parameters
 Albuminemia (miss=1) (g/l) 25.5 [23.1; 27.4]/(18.2|31.5) 35–52
 Cholesterol (miss=8) (g/l) 3.2 [2.5; 4]/(1.8|4) < 2
 TG (miss=4) (g/l) 2.1 [1.3; 2.4]/(1.1|2.8) <1.5
 Glycemia (g/l) 1.5 [1.2; 1.8]/(0.9|3.3) <1.2
 Lactate (mM/l) 1.3 [1; 1.5]/(0.8|1.6) <2
Outcomes
 VAP 4 (26.7)
 Delay before VAP (miss=11) 13.5 [7; 15.5]/(1|17)
 ICU LOS 12 [10; 23]/(5|30)
 Death 3 (20)

Data are expressed as medians [Interquartile IQ] or percentages (%). SAPS2: simplified acute physiological score; SOFA, sequential organ failure assessment; VAP, ventilatory acquired pneumonia; COPD, chronic obstructive pulmonary disease; SAS, sleep apnea syndrome; PCT, procalcitonin; LDH, Lactate dehydrogenase; CRP, C-reactive protein; C3, C4, complement fractions; TG, triglycerides.